4:06 PM
 | 
Nov 26, 2018
 |  BC Extra  |  Financial News

Neurodegeneration play Rheostat raises $23M series A

Rheostat Therapeutics (Cambridge, Mass.) raised $23 million in a series A round to bring its first programs in neurodegenerative disease to IND.

The round was co-led by MRL Ventures Fund and AbbVie Ventures, with participation from new investors Amgen Ventures, Alexandria Venture Investments and Mayo Clinic as well...

Read the full 221 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >